Is hMPV similar to COVID-19?

Human metapneumovirus (hMPV)

 The respiratory virus known as human metapneumovirus (hMPV) was discovered for the first time in 2001. It is closely connected to the respiratory syncytial virus (RSV) and mostly affects the respiratory tract. Globally, hMPV is a major source of respiratory infections, particularly in young children, the elderly, and those with compromised immune systems.

symptoms:

 Fever, coughing, nasal congestion, breathing difficulties, and, in more severe instances, wheezing, are typical signs of hMPV. Since these symptoms resemble those of influenza and RSV, a diagnosis based solely on symptoms is challenging.

Transmission:

 hMPV is transmitted by touching directly with contaminated hands or surfaces, as well as respiratory droplets through coughing or sneezing. The end of the winter and the beginning of spring are prime times for outbreaks, particularly in crowded settings like schools and assisted living facilities.

 Since they have never been infected with the virus, young kids under five are more vulnerable to hMPV. Weaker immune systems make older folks more susceptible, and those with weakened immune systems may experience more serious sickness. Lab tests are used to make the diagnosis, but no particular treatment is offered. Fever control, treatment with oxygen for serious cases, and water are all part of the care. Cleaning surfaces, avoiding sick people, and washing your hands are all ways to prevent infection. Since hMPV can result in severe side effects, including pneumonia, research is still being done even though there is currently no vaccine.

Rising cases in China?

 China is seeing an increase in hMPV cases as a result of the cold weather, which encourages people to stay indoors and spread diseases. The increase in cases is accompanied by cold temperatures in northern China that are predicted to last until March. Other northern hemisphere nations are also experiencing comparable wintertime rises.

Is hMPV similar to COVID-19?

 According to experts, concerns about a pandemic of HMPV similar to COVID-19 are unfounded because HMPV is not a new virus, unlike pandemics. Due to previous exposure, the majority of people, particularly kids, have some immunity to the virus, which has been present for decades. Almost every child will have experienced no less than one hMPV infection by the time they are five years old. Even if there are no indications of a worldwide emergency, people can lower their risk of respiratory illnesses by taking preventative measures, including using masks, avoiding crowds if they are at risk, maintaining proper hygiene, and getting vaccinated against the flu.

Key highlights of HMPV:

• First discovered: in 2001.
• Symptoms: fever, coughing, congestion of the nose, wheezing, and shortness of breath are the symptoms.
• Risk Groups: Impacts older persons, children, and people with compromised immune systems.
• Transmission: Spreads by contact with infected surfaces and respiratory droplets.
• Seasonality: Late winter and spring are the busiest times.
• Treatment: Supportive care is essential; no particular antivirals are needed.
• Prevention: Prevention includes cleaning surfaces, avoiding ill people, and practicing good hand hygiene.